Evommune, Inc. (EVMN)

Evommune Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	29.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$66,667
Profits Per Employee	-$1.47M
Employee Count	45
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evommune had revenue of $3.00 million and -$66.26 million in losses.

Revenue	3.00M
Gross Profit	3.00M
Operating Income	-76.00M
Pretax Income	-66.26M
Net Income	-66.26M
EBITDA	-67.18M
EBIT	-68.63M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $86.80 million in cash and $71,000 in debt, giving a net cash position of $86.72 million.

Cash & Cash Equivalents	86.80M
Total Debt	71,000
Net Cash	86.72M
Net Cash Per Share	n/a
Equity (Book Value)	-171.23M
Book Value Per Share	n/a
Working Capital	84.80M

Cash Flow

Operating Cash Flow	-94.85M
Capital Expenditures	n/a
Free Cash Flow	-94.85M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -2,533.20% and -2,208.80%.

Gross Margin	100.00%
Operating Margin	-2,533.20%
Pretax Margin	-2,208.80%
Profit Margin	-2,208.80%
EBITDA Margin	-2,239.40%
EBIT Margin	-2,287.50%
FCF Margin	-3,161.53%

Dividends & Yields

Evommune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a